Data as of 10:43am ET
| +0.02 / +1.56%|
The 1 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +207.69% increase from the last price of 1.30.
The current consensus among 1 polled investment analysts is to Buy stock in PharmAthene Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.